In late April, on his birthday, Michael Pickering — executive director of RAP, Inc. — got an unexpected surprise. It wasn’t a good one. One of RAP’s substance use disorder (SUD) patients had become symptomatic with COVID-19. From there, things snowballed, with two dozen patients and staff testing positive for the coronavirus in the days […]
